Supriya Peshin/X
Jun 4, 2025, 09:59
Supriya Peshin: ASCO25 – Spotlight on SC Anal Cancer and the Push for Innovation
Supriya Peshin, Visiting Resident in Hematology and Oncology at MD Anderson Cancer Center, shared a post on X:
“Once overshadowed in oncology discourse, SC anal cancer is now commanding attention, driven by the rise in HPV-associated cases and the unmet need in therapeutic innovation.
At ASCO25, the spotlight intensifies:
Immunogenomic profiling
HIV+ patient outcomes
Retifanlimab trials
Genomic-guided targeted therapy
This year’s robust presence of SCAC research signals a call to action to raise awareness, accelerate discovery, and champion equity in care for this often neglected malignancy.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 19, 2025, 11:05
Jul 19, 2025, 10:29
Jul 19, 2025, 10:12
Jul 19, 2025, 09:55
Jul 19, 2025, 09:05
Jul 19, 2025, 08:54
Jul 19, 2025, 07:24
Jul 19, 2025, 07:23